Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Saccharomyces cerevisiae
SIP3
gene was identified in a two-hybrid screen for proteins that interact in vivo with the SNF1
protein kinase
, which is necessary for release of glucose repression. We showed that the C-terminal part of
SIP3
, recovered through its ability to interact with SNF1, strongly activates transcription when tethered to DNA. We have cloned and sequenced the entire
SIP3
gene. The predicted 142-kD
SIP3
protein contains a putative leucine zipper motif located in its C terminus. The native
SIP3
protein also interacts with DNA-bound SNF1 and activates transcription of a target gene. A complete deletion of the
SIP3
gene did not confer phenotypes characteristic of snf1 mutants. However, in a mutant deficient for the SNF1 kinase activity due to loss of the SNF4 stimulatory function, increased dosage of
SIP3
partially restored expression of the glucose-repressible SUC2 gene. Overexpression of the C terminus of
SIP3
caused defects in growth and SUC2 expression which were remedied by overexpressing SNF1. Taken together, these genetic data suggest that
SIP3
is functionally related to the SNF1
protein kinase
pathway.
...
PMID:Analysis of the SIP3 protein identified in a two-hybrid screen for interaction with the SNF1 protein kinase. 812 9